Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dipeptidyl-Peptidase IV Inhibitors | 14 | 2025 | 317 | 2.710 |
Why?
|
Renal Insufficiency, Chronic | 15 | 2023 | 2308 | 2.580 |
Why?
|
Spinal Fractures | 6 | 2022 | 703 | 2.390 |
Why?
|
Diabetes Mellitus, Type 2 | 24 | 2025 | 12237 | 1.760 |
Why?
|
Nephrolithiasis | 2 | 2024 | 117 | 1.600 |
Why?
|
Hyperkalemia | 3 | 2024 | 233 | 1.600 |
Why?
|
Diabetic Nephropathies | 3 | 2022 | 969 | 1.300 |
Why?
|
Polypharmacy | 3 | 2021 | 306 | 1.280 |
Why?
|
Fractures, Bone | 6 | 2023 | 2041 | 1.140 |
Why?
|
Hip Fractures | 3 | 2022 | 997 | 1.120 |
Why?
|
Geriatrics | 2 | 2022 | 395 | 1.070 |
Why?
|
Glucosides | 8 | 2025 | 531 | 1.000 |
Why?
|
Nephrology | 2 | 2019 | 270 | 1.000 |
Why?
|
Benzhydryl Compounds | 8 | 2025 | 939 | 0.970 |
Why?
|
Hypoglycemic Agents | 18 | 2024 | 3108 | 0.950 |
Why?
|
Diabetic Ketoacidosis | 3 | 2023 | 252 | 0.950 |
Why?
|
Pharmacists | 3 | 2019 | 261 | 0.810 |
Why?
|
Kidney Failure, Chronic | 4 | 2021 | 2499 | 0.730 |
Why?
|
Veterans | 7 | 2023 | 2667 | 0.680 |
Why?
|
Calcium | 5 | 2023 | 5765 | 0.670 |
Why?
|
Renal Dialysis | 6 | 2021 | 1801 | 0.650 |
Why?
|
Kidney | 6 | 2023 | 7073 | 0.640 |
Why?
|
International Classification of Diseases | 2 | 2021 | 934 | 0.630 |
Why?
|
House Calls | 1 | 2020 | 171 | 0.610 |
Why?
|
Cardiovascular Diseases | 12 | 2024 | 15647 | 0.600 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 279 | 0.600 |
Why?
|
Gout | 3 | 2024 | 620 | 0.550 |
Why?
|
Histamine H2 Antagonists | 1 | 2018 | 168 | 0.540 |
Why?
|
Urinary Tract Infections | 1 | 2023 | 805 | 0.530 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2016 | 77 | 0.520 |
Why?
|
Parathyroid Hormone | 3 | 2012 | 1789 | 0.520 |
Why?
|
Proton Pump Inhibitors | 2 | 2018 | 553 | 0.520 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 211 | 0.510 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3836 | 0.500 |
Why?
|
Waist Circumference | 1 | 2019 | 934 | 0.490 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 157 | 0.480 |
Why?
|
Cohort Studies | 26 | 2024 | 41652 | 0.480 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2015 | 333 | 0.470 |
Why?
|
Wrist Injuries | 1 | 2017 | 215 | 0.460 |
Why?
|
Nephrotic Syndrome | 2 | 2015 | 380 | 0.450 |
Why?
|
Hyponatremia | 1 | 2016 | 278 | 0.440 |
Why?
|
Patient Care | 1 | 2019 | 629 | 0.430 |
Why?
|
Body Mass Index | 5 | 2024 | 13044 | 0.430 |
Why?
|
Heart Failure | 6 | 2024 | 11839 | 0.410 |
Why?
|
Aged | 40 | 2025 | 171233 | 0.410 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 415 | 0.410 |
Why?
|
Drug Prescriptions | 1 | 2021 | 1663 | 0.390 |
Why?
|
Calcium, Dietary | 2 | 2023 | 526 | 0.370 |
Why?
|
Osteoporosis | 2 | 2021 | 1582 | 0.360 |
Why?
|
Hyperthyroidism | 1 | 2012 | 293 | 0.350 |
Why?
|
Dietary Supplements | 2 | 2014 | 3424 | 0.350 |
Why?
|
Humans | 74 | 2025 | 766011 | 0.330 |
Why?
|
Medication Adherence | 2 | 2022 | 2190 | 0.330 |
Why?
|
Nurses | 3 | 2023 | 2505 | 0.330 |
Why?
|
Stroke | 5 | 2024 | 9750 | 0.320 |
Why?
|
Phosphorus | 1 | 2010 | 337 | 0.320 |
Why?
|
United States | 28 | 2025 | 72914 | 0.290 |
Why?
|
Myocardial Infarction | 4 | 2024 | 11506 | 0.290 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 1899 | 0.280 |
Why?
|
Bone Density | 2 | 2017 | 3490 | 0.270 |
Why?
|
Female | 46 | 2025 | 396159 | 0.270 |
Why?
|
Glucocorticoids | 2 | 2015 | 2132 | 0.260 |
Why?
|
Hypoglycemia | 2 | 2023 | 896 | 0.250 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2233 | 0.250 |
Why?
|
Medicare | 12 | 2024 | 6821 | 0.250 |
Why?
|
Frail Elderly | 2 | 2022 | 785 | 0.240 |
Why?
|
Bone Density Conservation Agents | 1 | 2012 | 791 | 0.240 |
Why?
|
Adult | 29 | 2024 | 223109 | 0.240 |
Why?
|
Incidence | 11 | 2025 | 21507 | 0.240 |
Why?
|
Middle Aged | 32 | 2025 | 223058 | 0.230 |
Why?
|
Geriatric Assessment | 3 | 2022 | 1429 | 0.230 |
Why?
|
Prospective Studies | 11 | 2023 | 54818 | 0.220 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 4626 | 0.220 |
Why?
|
Nutrition Surveys | 1 | 2011 | 1741 | 0.220 |
Why?
|
Respiratory Aspiration | 1 | 2024 | 89 | 0.210 |
Why?
|
Atherosclerosis | 3 | 2024 | 3421 | 0.210 |
Why?
|
Algorithms | 2 | 2021 | 14061 | 0.210 |
Why?
|
Hyperparathyroidism, Primary | 2 | 2016 | 163 | 0.210 |
Why?
|
Hypovolemia | 1 | 2023 | 47 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3106 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3251 | 0.200 |
Why?
|
Silicates | 1 | 2022 | 49 | 0.200 |
Why?
|
Glucose | 5 | 2024 | 4333 | 0.190 |
Why?
|
Minerals | 1 | 2023 | 278 | 0.190 |
Why?
|
Sodium | 2 | 2024 | 1589 | 0.190 |
Why?
|
Pruritus | 2 | 2015 | 378 | 0.190 |
Why?
|
Risk Factors | 16 | 2025 | 74870 | 0.180 |
Why?
|
Risk Assessment | 6 | 2021 | 24299 | 0.180 |
Why?
|
Hydromorphone | 1 | 2021 | 70 | 0.170 |
Why?
|
Male | 30 | 2025 | 363808 | 0.170 |
Why?
|
Snoring | 1 | 2022 | 212 | 0.170 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1946 | 0.170 |
Why?
|
Vitamin D | 4 | 2023 | 3272 | 0.170 |
Why?
|
Self Report | 3 | 2022 | 3774 | 0.170 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5188 | 0.160 |
Why?
|
Phosphates | 1 | 2023 | 764 | 0.160 |
Why?
|
Education, Pharmacy | 1 | 2019 | 38 | 0.160 |
Why?
|
Hypertension | 2 | 2016 | 8627 | 0.160 |
Why?
|
Hyperphosphatemia | 1 | 2019 | 38 | 0.160 |
Why?
|
Renal Insufficiency | 2 | 2023 | 808 | 0.160 |
Why?
|
Lithium | 1 | 2022 | 599 | 0.150 |
Why?
|
Calcium Phosphates | 1 | 2019 | 171 | 0.150 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2024 | 888 | 0.150 |
Why?
|
Cold Ischemia | 1 | 2018 | 72 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2023 | 906 | 0.150 |
Why?
|
Vitamin A | 2 | 2011 | 610 | 0.150 |
Why?
|
Injections, Subcutaneous | 1 | 2019 | 682 | 0.140 |
Why?
|
Chelating Agents | 1 | 2019 | 379 | 0.140 |
Why?
|
Prospective Payment System | 1 | 2018 | 135 | 0.140 |
Why?
|
Fentanyl | 1 | 2021 | 457 | 0.140 |
Why?
|
Hearing | 1 | 2021 | 505 | 0.140 |
Why?
|
Publication Bias | 1 | 2017 | 157 | 0.140 |
Why?
|
Thrombotic Microangiopathies | 1 | 2018 | 125 | 0.130 |
Why?
|
Pilot Projects | 2 | 2020 | 8733 | 0.130 |
Why?
|
Hospice Care | 1 | 2023 | 678 | 0.130 |
Why?
|
Diphosphonates | 1 | 2021 | 625 | 0.130 |
Why?
|
Pyrazoles | 2 | 2023 | 2031 | 0.130 |
Why?
|
Hyperparathyroidism | 1 | 2017 | 337 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 904 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2025 | 1294 | 0.120 |
Why?
|
Proteinuria | 2 | 2015 | 606 | 0.120 |
Why?
|
Tissue and Organ Harvesting | 1 | 2018 | 373 | 0.120 |
Why?
|
Administration, Oral | 2 | 2021 | 4015 | 0.120 |
Why?
|
Polymers | 1 | 2022 | 1618 | 0.120 |
Why?
|
Hospitalization | 4 | 2024 | 10807 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1139 | 0.110 |
Why?
|
Body Size | 1 | 2017 | 459 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2024 | 997 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12969 | 0.110 |
Why?
|
Drug Interactions | 1 | 2018 | 1416 | 0.110 |
Why?
|
Comorbidity | 2 | 2020 | 10572 | 0.110 |
Why?
|
Hearing Loss | 1 | 2021 | 784 | 0.110 |
Why?
|
Spine | 1 | 2020 | 1133 | 0.110 |
Why?
|
Interprofessional Relations | 1 | 2019 | 999 | 0.100 |
Why?
|
Interviews as Topic | 1 | 2020 | 2741 | 0.100 |
Why?
|
Suicide, Attempted | 1 | 2022 | 1412 | 0.100 |
Why?
|
Bone and Bones | 1 | 2023 | 2554 | 0.100 |
Why?
|
Inpatients | 1 | 2024 | 2565 | 0.100 |
Why?
|
Ultraviolet Rays | 1 | 2017 | 1099 | 0.100 |
Why?
|
Sulfonylurea Compounds | 2 | 2023 | 220 | 0.100 |
Why?
|
Retrospective Studies | 9 | 2025 | 81522 | 0.090 |
Why?
|
Kidney Calculi | 1 | 2015 | 457 | 0.090 |
Why?
|
Transplantation Conditioning | 1 | 2018 | 1635 | 0.090 |
Why?
|
Age Factors | 3 | 2019 | 18384 | 0.090 |
Why?
|
Sex Factors | 2 | 2017 | 10605 | 0.090 |
Why?
|
Creatinine | 3 | 2023 | 1917 | 0.090 |
Why?
|
Mexican Americans | 1 | 2011 | 165 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3230 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14751 | 0.090 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2033 | 0.080 |
Why?
|
Uric Acid | 2 | 2016 | 808 | 0.080 |
Why?
|
Aspirin | 1 | 2021 | 3135 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10389 | 0.080 |
Why?
|
Pain Measurement | 1 | 2019 | 3560 | 0.080 |
Why?
|
Kidney Diseases | 1 | 2019 | 2098 | 0.080 |
Why?
|
Massachusetts | 1 | 2020 | 8878 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2024 | 59526 | 0.070 |
Why?
|
Adolescent | 4 | 2024 | 88804 | 0.070 |
Why?
|
Pyridones | 2 | 2023 | 816 | 0.070 |
Why?
|
Age Distribution | 1 | 2012 | 2865 | 0.070 |
Why?
|
Demography | 1 | 2011 | 1641 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2938 | 0.070 |
Why?
|
Health Surveys | 1 | 2016 | 4057 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 8062 | 0.060 |
Why?
|
Sleep | 1 | 2022 | 4823 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15403 | 0.060 |
Why?
|
Graft Rejection | 1 | 2018 | 4499 | 0.060 |
Why?
|
Diet | 2 | 2014 | 8085 | 0.060 |
Why?
|
Bipolar Disorder | 1 | 2022 | 5127 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5892 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9600 | 0.060 |
Why?
|
Seasons | 1 | 2010 | 1523 | 0.060 |
Why?
|
Propensity Score | 2 | 2024 | 1967 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4813 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3854 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15833 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4268 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12060 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5508 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 40117 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14645 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2022 | 88 | 0.050 |
Why?
|
Iohexol | 1 | 2023 | 205 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10731 | 0.050 |
Why?
|
Nurse's Role | 1 | 2023 | 187 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12520 | 0.050 |
Why?
|
Cystatin C | 1 | 2023 | 272 | 0.050 |
Why?
|
Ultrasonography | 1 | 2015 | 5997 | 0.050 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2021 | 89 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2025 | 39226 | 0.050 |
Why?
|
Hydrochlorothiazide | 1 | 2021 | 95 | 0.050 |
Why?
|
Milk | 1 | 2023 | 436 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8699 | 0.040 |
Why?
|
Audiometry | 1 | 2021 | 253 | 0.040 |
Why?
|
Dairy Products | 1 | 2023 | 491 | 0.040 |
Why?
|
Life Style | 1 | 2011 | 3929 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5753 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 59870 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2011 | 26283 | 0.040 |
Why?
|
Coronary Disease | 1 | 2014 | 5923 | 0.040 |
Why?
|
Health Status | 1 | 2012 | 4083 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5937 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2024 | 713 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 523 | 0.040 |
Why?
|
Anticoagulants | 2 | 2023 | 4863 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2023 | 1127 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 936 | 0.030 |
Why?
|
Maine | 1 | 2016 | 146 | 0.030 |
Why?
|
Warfarin | 1 | 2023 | 1494 | 0.030 |
Why?
|
Furosemide | 1 | 2015 | 175 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3710 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2229 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2024 | 1293 | 0.030 |
Why?
|
Mortality | 1 | 2024 | 2910 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1465 | 0.020 |
Why?
|
Health Care Costs | 1 | 2024 | 3243 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 65236 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4328 | 0.020 |
Why?
|
Calcinosis | 1 | 2019 | 1478 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4850 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3965 | 0.020 |
Why?
|
Insulin | 1 | 2023 | 6598 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3076 | 0.020 |
Why?
|
Disease Progression | 1 | 2025 | 13615 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12433 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3897 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 6207 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10086 | 0.020 |
Why?
|
Prognosis | 1 | 2023 | 29915 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8321 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 13078 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6544 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168721 | 0.010 |
Why?
|
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(69)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_